Apple
AAPL
Cisco
CSCO
Disney
DIS
Qualcomm
QCOM
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
AXGN AxoGen
- 18.500
- +0.140+0.76%
Close Mar 31 16:00 ET
- 18.500
- 0.0000.00%
Post 17:26 ET
820.36MMarket Cap-80.43P/E (TTM)
18.668High17.635Low1.16MVolume18.120Open18.360Pre Close21.42MTurnover2.99%Turnover RatioLossP/E (Static)44.34MShares21.00052wk High7.90P/B719.86MFloat Cap5.55052wk Low--Dividend TTM38.91MShs Float56.850Historical High--Div YieldTTM5.63%Amplitude0.164Historical Low18.407Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
AxoGen Stock Forum
In reaction to earnings/guidance:
• $Silvergate Capital (SI.US)$ +10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.)
• $AxoGen (AXGN.US)$ +3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization),
• $Novartis AG (NVS.US)$ + 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...
• $Intercept Pharmaceuticals (ICPT.US)$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $Albemarle (ALB.US)$ +13.9% (earnings reports)
• $Booking Holdings (BKNG.US)$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen (AXGN.US)$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $Cumulus Media (CMLS.US)$ +7.2% (an...
No comment yet